Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Risk Syndrome”

755 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 755 results

Testing effectiveness (Phase 2)Study completedNCT00533923
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCLL+6 more
Beth Israel Deaconess Medical Center 25
Not applicableEnrolling By InvitationNCT03713229
What this trial is testing

Seville Cohort of People Living With HIV at Risk for Anal Cancer

Who this might be right for
Anal Squamous Intraepithelial Neoplasia
Hospitales Universitarios Virgen del Rocío 3,000
Not applicableLooking for participantsNCT06326294
What this trial is testing

Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

Who this might be right for
HIV InfectionsHPV InfectionCIN 2/3
Instituto Nacional de Saúde, Mozambique 4,844
Not applicableUnknownNCT00365729
What this trial is testing

Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men

Who this might be right for
HIV InfectionsPapillomavirus InfectionsAnal Intraepithelial Neoplasia
Deutsche Luft und Raumfahrt 1,000
Not applicableStudy completedNCT00001560
What this trial is testing

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

Who this might be right for
Acquired Immunodeficiency SyndromeKaposi's SarcomaLeukemia+3 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT03661307
What this trial is testing

Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+2 more
M.D. Anderson Cancer Center 73
Early research (Phase 1)Looking for participantsNCT04375631
What this trial is testing

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic Syndrome+6 more
Fred Hutchinson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT02159872
What this trial is testing

Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Looking for participantsNCT04929028
What this trial is testing

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Who this might be right for
AIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell Carcinoma+7 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT01135329
What this trial is testing

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Who this might be right for
LymphomaLeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Looking for participantsNCT06566742
What this trial is testing

Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaClonal Cytopenia of Undetermined Significance
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT00144430
What this trial is testing

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

Who this might be right for
Graft vs Host Disease
Ann & Robert H Lurie Children's Hospital of Chicago 60
Not applicableStudy completedNCT01852721
What this trial is testing

Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women (ALIMED)-Part 2

Who this might be right for
Cardiovascular Diseases
Laval University 123
Not applicableStudy completedNCT07327164
What this trial is testing

Precision Medicine for Neurocutaneous Syndromes in Western China

Who this might be right for
Neurocutaneous SyndromesNeurofibromatosis Type 1 (NF1)Tuberous Sclerosis Complex (TSC)+2 more
West China Hospital 1,200
Early research (Phase 1)UnknownNCT01716364
What this trial is testing

Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Multiple MyelomaAcute Myeloid LeukaemiaMyelodysplastic Syndrome
Peter MacCallum Cancer Centre, Australia 6
Testing effectiveness (Phase 2)Study completedNCT00290992
What this trial is testing

Rasburicase for Hyperuricemia

Who this might be right for
Nutritional and Metabolic Diseases
Sanofi 30
Not applicableNot Yet RecruitingNCT07042971
What this trial is testing

Peri-operative BiPAP to Prevent Tracheostomy in High-Risk Bilateral Vocal-Cord Paralysis (BVCP)

Who this might be right for
Vocal Cord Paralysis, BilateralAirway Obstruction, PostoperativeThyroid Neoplasms+1 more
Fujian Medical University 204
Testing effectiveness (Phase 2)Ended earlyNCT05918055
What this trial is testing

Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06598969
What this trial is testing

TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesMyeloid Leukemia, Acute
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 58
Load More Results